This application requests continued support for MUSC?s KL2 program to build on programmatic successes by making innovative changes to strengthen all aspects of the program. This will be achieved by accomplishing the following specific objectives: (1) Promote state-of-the-art personalized training in translational research methods by focused coursework and opportunities for novel electives to prepare our scholars for productive careers as independent investigators; (2) Prepare our scholars to be biomedical research leaders through immersion in our rich interdisciplinary, trans-generational team science environment that features experiential learning, innovative problem solving and outstanding collaboration; and (3) Accelerate the growth and research productivity of our scholars using innovative mentoring and career management approaches and enhancing programmatic support. While each scholar creates and follows a personalized Individual Development Plan (IDP), all will participate in common key program activities that provide a core skill set in translational science and provide ample opportunity for interaction with other scholars and faculty to ensure that interdisciplinary collaborations are nurtured within the program. Programmatic successes to date are impressive: of the 17 program graduates, 15 (88.2%) have obtained extramural NIH or VA grant support as Principal Investigators, 13 (87%) of whom were successful within 3 years of entry into the program. There are 5 scholar positions in the program (3 funded by this award and 2 funded by institutional funds). Each scholar is appointed to the program for two years. If scholars are making satisfactory progress but have not yet obtained independent funding, they may be considered for a third year of programmatic support. Candidates must be faculty members who are recruited from both internal and external pools. Our KL2 program places great emphasis on cultivating a diverse cadre of scholars to develop the clinical and translational research workforce in South Carolina and beyond.

Agency
National Institute of Health (NIH)
Institute
National Center for Advancing Translational Sciences (NCATS)
Type
Mentored Career Development Award (KL2)
Project #
2KL2TR001452-06
Application #
10053831
Study Section
Special Emphasis Panel (ZTR1)
Program Officer
Gopal-Srivastava, Rashmi
Project Start
2015-08-13
Project End
2025-03-31
Budget Start
2020-04-01
Budget End
2021-03-31
Support Year
6
Fiscal Year
2020
Total Cost
Indirect Cost
Name
Medical University of South Carolina
Department
Type
DUNS #
183710748
City
Charleston
State
SC
Country
United States
Zip Code
29407
Taylor, Robert J; Schlosser, Rodney J; Soler, Zachary M et al. (2018) Glucocorticoid receptor isoform expression in peripheral blood mononuclear leukocytes of patients with chronic rhinosinusitis. Int Forum Allergy Rhinol :
McRackan, Theodore R; Bauschard, Michael; Hatch, Jonathan L et al. (2018) Meta-analysis of Cochlear Implantation Outcomes Evaluated With General Health-related Patient-reported Outcome Measures. Otol Neurotol 39:29-36
McRackan, Theodore R; Bauschard, Michael; Hatch, Jonathan L et al. (2018) Meta-analysis of quality-of-life improvement after cochlear implantation and associations with speech recognition abilities. Laryngoscope 128:982-990
Alawieh, Ali; Andersen, Meredith; Adkins, DeAnna L et al. (2018) Acute Complement Inhibition Potentiates Neurorehabilitation and Enhances tPA-Mediated Neuroprotection. J Neurosci 38:6527-6545
Alawieh, Ali; Langley, E Farris; Tomlinson, Stephen (2018) Targeted complement inhibition salvages stressed neurons and inhibits neuroinflammation after stroke in mice. Sci Transl Med 10:
Boerner, Ryan; Hatch, Jonathan L; Harruff, Elizabeth et al. (2018) Publishing Trends in Otology and Neurotology. Otol Neurotol 39:127-132
Schlenz, Alyssa M; Hayes, Joannie; Mueller, Martina et al. (2018) Incomplete implementation of guideline-based stroke prevention therapy in sickle cell disease. Am J Hematol 93:E222-E224
Mulligan, Jennifer K; Patel, Kunal; Williamson, Tucker et al. (2018) C3a receptor antagonism as a novel therapeutic target for chronic rhinosinusitis. Mucosal Immunol 11:1375-1385
McRackan, Theodore R; Clinkscales, William B; Ahlstrom, Jayne B et al. (2018) Factors associated with benefit of active middle ear implants compared to conventional hearing aids. Laryngoscope 128:2133-2138
Adams, Sarah Nicole; Abel, Mary; Fowler, Dustin et al. (2018) Inhaled corticosteroid prescribing in a pediatric emergency department: Sustained success and prescription filling rates. J Asthma 55:252-258

Showing the most recent 10 out of 26 publications